Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
18.52
+0.51 (2.83%)
Dec 19, 2025, 4:00 PM EST - Market closed
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $1.88 billion as of December 19, 2025. Its market cap has increased by 26.87% in one year.
Market Cap
1.88B
Enterprise Value
1.51B
1-Year Change
26.87%
Ranking
Category
Stock Price
$18.52
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $1.88B, an increase of 166.64%. That is a compound annual growth rate of 19.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 1.83B | 36.80% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | 1.28B | 81.45% |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 956.88B |
| Johnson & Johnson | 502.02B |
| AbbVie | 400.40B |
| UnitedHealth Group | 302.25B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 252.04B |
| Abbott Laboratories | 217.37B |